Ozaki Yukiko, an officer at Nomura Holdings, has reported the acquisition of shares in the company. This transaction, filed on October 26, 2026, is significant as it underscores the commitment of company executives to their own firm’s equity.
Nomura Holdings Inc, a prominent entity in the securities industry, operates under the classification of security brokers, dealers, and flotation companies. The firm is publicly traded on exchanges, with its trading symbol being NMR in the U.S. and TSE: 8604 in Japan. The company is headquartered in Tokyo, Japan.
According to the filing, Ozaki Yukiko acquired 6.936 shares of common stock on October 23, 2026, at a price of $9.20 per share. Following this transaction, Yukiko holds a total of 87.724 shares in Nomura Holdings. The shares are held in an officer's stock ownership plan, reflecting a direct ownership stake in the company.
This transaction may impact stakeholders, including other executives and shareholders, as it demonstrates ongoing executive investment in the firm. Such actions can influence market perception and investor confidence in Nomura Holdings.
The filing does not say what happens next.
Details of the Acquisition
Ozaki Yukiko's acquisition of 6.936 shares was executed on October 23, 2026, at a price of $9.20 per share. This price reflects a conversion from Japanese yen, utilizing an exchange rate of JPY156.51 to USD1, as reported by MUFG Bank, Ltd on the transaction date.
Following this acquisition, Yukiko's total holdings in Nomura Holdings amount to 87.724 shares, which are held in an officer's stock ownership plan, indicating a direct ownership stake in the firm.
Additional Context
The filing also notes that there were transfers of 100 shares from the officer's stock ownership plan account to a brokerage account in Yukiko's name on June 25, 2026. These transfers, however, did not alter the total amount of securities beneficially owned by Yukiko since her last filing on Form 4 on May 25, 2026.
Ozaki Yukiko holds the title of Chief Human Resources Officer (CHRO) and Chief Health Officer (CHO), which adds significance to her investment in the company as it reflects her confidence in the future of Nomura Holdings.
"The reported price has been converted into U.S. dollars from Japanese yen using the JPY156.51 = US$1 as spot exchange rate on the Transaction Date."











